97062 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
CHEMOKINE RESPONSIVE ACTIVATED NATURAL KILLER CELLS WITH SECONDARY HOMING ACTIVATION FOR VERIFIED TARGETS
#2CHIMERIC COSTIMULATORY RECEPTORS, CHEMOKINE RECEPTORS, AND THE USE OF SAME IN CELLULAR IMMUNOTHERAPIES
#3CANCER ANTIGEN TARGETS AND USES THEREOF
#4Safety Kill Switches for Engineered Cells Carrying Synthetic Chromosomes
#5GENETIC ENGINEERING OF ENDOGENOUS PROTEINS
#6GENETICALLY ENGINEERED CELLS AND USES THEREOF
#7TARGETED PROTEIN DEGRADATION SYSTEM AND USE THEREOF
#8MULTIVALENT DISPLAY ON ENVELOPED PARTICLES WITH HUMAN OLIGOMERIZATION DOMAINS
#9IMMORTALIZED CELLS FOR PRODUCTION OF BIOPRODUCTS, METHODS OF PRODUCING BIOPRODUCTS WITH AN IMMORTALIZED CELL, AND METHODS OF MAKING IMMORTALIZED CELLS FOR PRODUCTION OF BIOPRODUCTS
#10MODIFIED HEMATOPOIETIC STEM CELLS AND USES THEREOF
#11IDENTIFICATION, IN VITRO AMPLIFICATION, AND APPLICATION METHOD OF MEMORY CD8 T CELLS SPECIFIC FOR TUMOR ANTIGEN
#12COMPUTER-IMPLEMENTED DESIGN OF PEPTIDE:RECEPTOR SIGNALING COMPLEXES FOR ENHANCED CHEMOTAXIS
#13Use Of Chemokine Receptors In Cellular Homing
#14Synthetic Chromosome Encoding Two Or More Chimeric Antigen Receptors Binding To Tumor Associated Antigens
#15NK CELLS WITH AN INCREASED ANTIBODY-DEPENDENT CELLULAR TOXICITY (ADCC) AGAINST TUMORS
#16HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY
#17GENE-MODIFIED PLURIPOTENT STEM CELL, IMMUNOCOMPETENT CELL DERIVED THEREFROM, METHOD FOR PRODUCING SAID CELLS, AND USE THEREOF
#18Oncolytic Immunotherapy by Tumor Micro-Environment Remodeling
#19Oncolytic Immunotherapy by Tumor Micro-Environment Remodeling
#20Chimeric Natural Killer Cell Receptors and Method of Using Thereof
#21CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS
#22CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS
#23MULTIPROTEIN-ENGINEERED CELLS SECRETING A MULTISPECIFIC ANTIBODY
#24IMPROVED ADOPTIVE CELL TRANSFER THERAPY FOR CANCER
#25FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS
#26FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS
#27DIFFERENTIAL CXCR4 EXPRESSION ON HEMATOPOIETIC PROGENITOR CELLS VERSUS STEM CELLS DIRECTS HOMING AND LONG-TERM ENGRAFTMENT
#28CX3CR1-BINDING POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#29METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASE
#30COMPOSITIONS AND METHODS FOR PRODUCING AND USING CELL-BASED IMMUNOTHERAPIES TO TARGET TUMORS
#31HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY
#32METHODS FOR INCREASING T-CELL FUNCTION
#33CHIMERIC ANTIGEN RECEPTOR FUSION PROTEIN CO-EXPRESSING IL-7 AND CCR2B, AND APPLICATION THEREOF
#34EDITING OF CCR5 RECEPTOR GENE TO PROTECT AGAINST HIV INFECTION
#35CCR6 ANTIBODIES
#36PRE-IMMUNIZATION AND IMMUNOTHERAPY
#37PRE-IMMUNIZATION AND IMMUNOTHERAPY
#38T CELLS MODIFIED TO EXPRESS MUTATED CXCR4 OR PARTIALLY DELETED AND USES THEREOF
#39A CXCR3+ CELL OR CELL PREPARATION FOR USE IN CANCER TREATMENT
#40CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELL EXPRESSING CXCL12 RECEPTOR
#41METHODS AND COMPOSITIONS
#42CX3CR1-BINDING POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#43MESENCHYMAL STEM CELLS CO-EXPRESSING CXCR4 AND IL-10 AND USES THEREOF
#44GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC CCR8
#45T CELLS EXPRESSING CHEMOKINE RECEPTORS FOR TREATING CANCER
#46Modified Antibody
#47HYBRID ALLOSTERIC RECEPTOR-ENGINEERED STEM CELLS
#48QTY FC Fusion Water Soluble GPCR Proteins
#49Oncolytic Immunotherapy by Tumor Micro-Environment Remodeling
#50SULFATED PEPTIDES FOR CHEMOKINE RECEPTOR ANTIBODY GENERATION
#51CHEMOKINE-SELECTIVE CXCR4 ECTODOMAIN-DERIVED (POLY)PEPTIDE
#52HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY
#53Methods for increasing T-cell function
#54LONG LIVED T CELLS FOR TREATING HIV INFECTION
#55QTY Fc fusion receptor proteins
#56TOOLS AND METHODS FOR EXPRESSION OF MEMBRANE PROTEINS
#57Modified Antibody
#58Nucleic acids encoding CX3CR1-binding polypeptides comprising immunoglobulin single variable domains
#59Methods of treatment using CCR8 antibodies
#60INTRACELLULAR GENOMIC TRANSPLANT AND METHODS OF THERAPY
#61S-LAYER PROTEIN 2D LATTICE COUPLED DETERGENT-FREE GPCR BIOELECTRONIC INTERFACES, DEVICES, AND METHODS FOR USE THEREOF
#62IMMUNE EFFECTOR CELL FOR CO-EXPRESSING CHEMOKINE RECEPTOR
#63METHODS AND COMPOSITIONS FOR RECONSTITUTING MICROGLIA
#64FUSION PROTEINS AND USES THEREOF
#65DIMER IMMUNOADHESIN, PHARMACEUTICAL COMPOSTION AND USE THEREOF
#66EVASINS FOR USE IN THERAPY AND DIAGNOSTICS
#67NON-HUMAN ANIMALS HAVING AN IMMUNOGLOBULIN HEAVY CHAIN VARIABLE REGION THAT INCLUDES AN ENGINEERED DIVERSITY CLUSTER AND USES THEREOF
#68Platform Oncolytic Vector for Systemic Delivery
#69MODIFIED CELLS AND METHODS OF THERAPY
#70ADVANCED CHIMERIC ANTIGEN RECEPTOR VECTORS FOR TARGETING SOLID TUMORS
#71TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY
#72CHIMERIC ANTIGEN RECEPTORS WITH ENHANCED TUMOR INFILTRATION
#73CANCER ANTIGEN TARGETS AND USES THEREOF
#74Platform oncolytic vector for systemic delivery
#75TUMOR-SPECIFIC ANTI-EGFR ANTIBODY AND APPLICATION THEREOF
#76Platform oncolytic vector for systemic delivery
#77Integral membrane protein display on poxvirus extracellular enveloped virions
#78Non-Signaling HIV Fusion Inhibitors And Methods Of Use Thereof
#79HIV pre-immunization and immunotherapy
#80CHEMOKINE RESPONSIVE ACTIVATED NATURAL KILLER CELLS WITH SECONDARY HOMING ACTIVATION FOR VERIFIED TARGETS
#81Anti-CXC chemokine receptor antibodies and C-X-C chemokines for the diagnosis of autoimmune disease and graft-versus-host disease
#82QTY FC fusion receptor proteins
#83Modified cells and methods of therapy
#84CAR-T LYMPHOCYTES ENGINEERED TO HOME TO LYMPH NODE B CELL ZONE, SKIN, OR GASTROINTESTINAL TRACT
#85HIV antibody derivatives with dual antiviral and immunomodulatory activities from CD4 and GP41
#86Use of chemokine receptor CXCR5
#87GENETIC ENGINEERING OF ENDOGENOUS PROTEINS
#88PLATFORM ONCOLYTIC VECTOR FOR SYSTEMIC DELIVERY
#89PAN-CANCER T CELL EXHAUSTION GENES
#90RECOMBINANT ADENO-ASSOCIATED VIRUS-MEDIATED EXPRESSION OF FRACTALKINE FOR TREATMENT OF NEUROINFLAMMATORY AND NEURODEGENERATIVE DISEASES
#91FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS
#92Platform oncolytic vector for systemic delivery
#93BLOCKADE OF CCL18 SIGNALING VIA CCR6 AS A THERAPEUTIC OPTION IN FIBROTIC DISEASES AND CANCER
#94Editing of CCR2 receptor gene to protect against HIV infection
#95Sequence specific reagents targeting CCR5 in primary hematopoietic cells
#96NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors
#97Intracellular genomic transplant and methods of therapy
#98N-terminal recombinant protein of CCR4 and use thereof
#99TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY
#100Chimeric Natural Killer Cell Receptors and Method of Using Thereof
#101Intracellular genomic transplant and methods of therapy
#102INTRACELLULAR GENOMIC TRANSPLANT AND METHODS OF THERAPY
#103TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY
#104Tumor infiltrating lymphocytes and methods of therapy
#105Integral membrane protein display on poxvirus extracellular enveloped virions
#106Cancer antigen targets and uses thereof
#107FC-FUSION PROTEIN DERIVATIVES WITH HIGH DUAL HIV ANTIVIRAL AND IMMUNOMODULATORY ACTIVITY
#108HIV pre-immunization and immunotherapy
#109Anti-CXCR4 antibodies and antibody-drug conjugates
#110Inhibition of Chemokine CCL7 or Receptor CCR3 of Same for the Treatment and Diagnosis of Prostate Cancer
#111METHODS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#112T CELLS EXPRESSING CHEMOKINE RECEPTORS FOR TREATING CANCER
#113Treatment of -associated Waldenstrom's macroglobulinemia with an anti-CXCR4 antibody
#114Peptide inhibition of CCR3-mediated diseases or conditions
#115Antibody targeting IL-13RA2 and use thereof
#116S-layer protein 2D lattice coupled detergent-free GPCR bioelectronic interfaces, devices, and methods for the use thereof
#117Integral membrane protein display on poxvirus extracellular enveloped virions
#118Transgenic VERO-CD4/CCR5 cell line
#119HIV pre-immunization and immunotherapy
#120Integral membrane protein display on poxvirus extracellular enveloped virions
#121Anti-CXCR4 antibodies and antibody-drug conjugates
#122NK cells with altered CXCL12/CXCR4 signaling
#123Engineered antigen presenting cells and uses thereof
#124Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof
#125Intracellular genomic transplant and methods of therapy
#126Intracellular genomic transplant and methods of therapy
#127Intracellular genomic transplant and methods of therapy
#128RODENTS HAVING AN ENGINEERED HEAVY CHAIN DIVERSITY REGION
#129Cytokine receptor peptides, compositions thereof and methods thereof
#130Tumor infiltrating lymphocytes and methods of therapy
#131THERAPEUTIC T CELLS
#132COMPOSITIONS AND METHODS FOR IMPROVING IMMUNOTHERAPY
#133Cancer antigen targets and uses thereof
#134Modulation of CCR10 signals for treatment of skin and intestinal inflammatory diseases and infection
#135Tumor-specific anti-EGFR antibody and application thereof
#136MODIFIED IMMUNE CELLS AND USES THEREOF
#137NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors
#138WATER SOLUBLE MEMBRANE PROTEINS AND METHODS FOR THE PREPARATION AND USE THEREOF
#139CXCR antagonistic peptides and uses thereof
#140CXCR6-transduced T cells for targeted tumor therapy
#141CCR2 antagonist peptides
#142Tools and methods for expression of membrane proteins
#143Editing of CCR5 receptor gene to protect against HIV infection
#144ENGINEERED REPLACEMENT OF PARTIAL VARIANT WATER SOLUBLE MEMBRANE PROTEINS
#145CAR-T LYMPHOCYTES ENGINEERED TO HOME TO LYMPH NODE B CELL ZONE, SKIN, OR GASTROINTESTINAL TRACT
#146Human CDR-grafted antibody and antibody fragment thereof
#147Anti-CXCR4 antibodies and antibody-drug conjugates
#148Peptide inhibition of CCR3-mediated diseases or conditions
#149Transgenic Vero-CD4/CCR5 cell line
#150CONSTANT REGION ANTIBODY FUSION PROTEINS AND COMPOSITIONS THEREOF
#151Endothelial-targeted Adenoviral Vectors, Methods and Uses Therefor
#152Inhibition of chemokine CCL7 or receptor CCR3 of same for the treatment and diagnosis of prostate cancer
#153Intracellular genomic transplant and methods of therapy
#154Fusion proteins and uses thereof
#155Methods and compositions for modulating immune tolerance
#156Prophylaxis Against Cancer Metastasis
#157Modified cells and methods of therapy
#158Modified cells and methods of therapy
#159CCR2 ANTAGONIST PEPTIDES
#160Humanized monoclonal antibodies and methods of use
#161CCR5 disruption of cells expressing anti-HIV chimeric antigen receptor (CAR) derived from broadly neutralizing antibodies
#162IDENTIFICATION OF CXCR8, A NOVEL CHEMOKINE RECEPTOR
#163Blockade of CCL18 signaling via CCR6 as a therapeutic option in treating interstitial lung disease
#164Cytokine receptor peptides, compositions thereof and methods thereof
#165CXCR antagonistic peptides and uses thereof
#166MTOR/STAT3 signal inhibitor-treated mesenchymal stem cell having immunomodulatory activity, and cell therapy composition comprising same, for preventing or treating immune disorders
#167Water soluble membrane proteins and methods for the preparation and use thereof
#168Humanized monoclonal antibodies and methods of use
#169Endothelial-targeted Adenoviral Vectors, Methods and Uses Therefor
#170Modified antibody
#171Human CDR-grafted antibody and antibody fragment thereof
#172Template-fixed peptidomimetics with CXCR7 modulating activity
#173Modulation of CCR10 signals for treatment of skin and intestinal inflammatory diseases and infection
#174Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof
#175Mammal with an orthotopic tumor capable of metastasis, a method of making and a method of using
#176Modification of CXCR4 using engineered zinc finger proteins
#177Anti-CXCR4 antibodies and antibody-drug conjugates
#178CCR2 antagonist peptides
#179Cytokine receptor peptides, compositions thereof and methods thereof
#180Tools and methods for expression of membrane proteins
#181Methods and compositions for modulating immune tolerance
#182Combination anti-HIV vectors, targeting vectors, and methods of use
#183Water soluble membrane proteins and methods for the preparation and use thereof
#184Recombinant adeno-associated virus-mediated expression of fractalkine for treatment of neuroinflammatory and neurodegenerative diseases
#185Human CDR-grafted antibody and antibody fragment thereof
#186Chemokine binding polypeptides for treating autoimmunity and inflammation
#187Methods for treatment of age-related macular degeneration
#188Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
#189Human CDR-grafted antibody and antibody fragment thereof
#190Template-fixed peptidomimetics with CXCR7 modulating activity
#191CXCR4 receptor compounds
#192Human G-protein chemokine receptor HSATU68
#193BLOCKADE OF CCL18 SIGNALING VIA CCR6 AS A THERAPEUTIC OPTION IN FIBROTIC DISEASES AND CANCER
#194Humanized anti-CCR2 antibodies and methods of use therefor
#195CXCR4 receptor compounds
#196Water soluble membrane proteins and methods for the preparation and use thereof
#197HUMAN CDR-GRAFTED ANTIBODY AND ANTIBODY FRAGMENT THEREOF
#198MODIFIED IPS CELLS HAVING A MUTANT FORM OF A HUMAN IMMUNODEFICIENCY VIRUS (HIV) CELLULAR ENTRY GENE
#199Modified antibody
#200Novel Receptor Hetero-Dimers/-Oligomers
#201Methods and compositions for inhibiting viral entry into cells
#202THERAPEUTICS FOR AGE-RELATED MACULAR DEGENERATION
#203Chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer
#204Combination anti-HIV vectors, targeting vectors, and methods of use
#205THERAPEUTIC METHOD FOR INCREASING PANCREATIC BETA CELL MASS
#206APJ RECEPTOR COMPOUNDS
#207NUCLEIC ACID ENCODING FUSION POLYPEPTIDES THAT PREVENT OR INHIBIT HIV INFECTION
#208CXCR5 RECEPTOR COMPOUNDS
#209Stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them
#210High affinity recombinant sea lamprey antibodies selected by a Yeast Surface Display platform
#211TARGETED COSTIMULATORY POLYPEPTIDES AND METHODS OF USE TO TREAT CANCER
#212Human G-Protein Chemokine Receptor (CCR5) HDGNR10
#213PD-1 ANTAGONISTS AND METHODS OF USE THEREOF
#214Humanized monoclonal antibodies and methods of use
#215HYBRID PROTEINS COMPRISING MEMBRANE RECEPTOR AND ION CHANNEL, AND THEIR USE AS BIOSENSORS
#216PD-1 ANTAGONISTS AND METHODS FOR TREATING INFECTIOUS DISEASE
#217CC CHEMOKINE RECEPTOR 5 DNA, NEW ANIMAL MODELS AND THERAPEUTIC AGENTS FOR HIV INFECTION
#218Methods and compositions for modulating immune tolerance
#219Human G-Protein Chemokine Receptor (CCR5) HDGNR10
#220Human CDR-grafted antibody and antibody fragment thereof
#221IMMUNOGENIC COMPOUNDS AND PROTEIN MIMICS
#222Modification of CXCR4 using engineered zinc finger proteins
#223Human G-Protein Chemokine Receptor (CCR5) HDGNR10
#224Molecules and methods of using same for treating CCR5/CCR5 ligands associated diseases
#225METHODS FOR DETECTING AND TREATING KIDNEY DISEASE
#226MAMMALIAN CHEMOKINES; RECEPTORS; REAGENTS; USES
#227Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
#228Method of inhibiting leukocytes with human cxc chemokine receptor 3 antibody
#229Cytokine receptor peptides, compositions thereof and methods thereof
#230Synthetic Dog/Human Chimeric C-C Chemokine Receptor 2B
#231Modulation of T cell recruitment
#232Type 2 cytokine receptor and nucleic acids encoding same
#233Human CDR-grafted antibody and antibody fragment thereof
#234Method of inhibiting human G-protein chemokine receptor (CCR5) HDGNR10
#235Pharmaceutical composition comprising cxcr3 inhibitor
#236MAMMALIAN CHEMOKINE REAGENTS
#237Humanized anti-CCR2 antibodies and methods of use therefor
#238HUMAN SIGNAL PEPTIDE-CONTAINING PROTEINS
#239Phosphospecific chemokine receptor antibodies
#240Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
#241Methods of screening for antagonists of mammalian monocyte chemoattractant protein receptors
#242Method of diagnosis of inflammatory disease using eotaxin antibodies
#243C-C chemokine receptor 3 proteins
#244Polypeptides and compositions comprising same and methods of using same for treating cxcr4 associated medical conditions
#245Antibodies Against Human G-Protein Chemokine Receptor (CCR5) HDGNR10
#246Binding compounds, immunogenic compounds and peptidomimetics
#247Human G-Protein Receptor HGBER32
#248CC CHEMOKINE RECEPTOR 5 DNA, NEW ANIMAL MODELS AND THERAPEUTIC AGENTS FOR HIV INFECTION
#249Human G-Protein Chemokine Receptor (CCR5) HDGNR10
#250G protein coupled receptor agonists and antagonists and methods of use
#251Virus-like particles for the induction of autoantibodies
#252MAMMALIAN CHEMOKINES; RECEPTORS; REAGENTS; USES
#253Antibodies to human eotaxin
#254MAMMALIAN CHEMOKINE REAGENTS
#255Synthetic dog/human chimeric C-C chemokine receptor 2B
#256Methods for detecting and treating kidney disease
#257Chemokine receptor materials and methods
#258Stem Cells Suitable for Transplantation, their Preparation and Pharmaceutical Compositions Comprising Them
#259Methods for altering cellular susceptibility to infection
#260Immunogenic proteoliposomes, and uses thereof
#261Nucleic acid encoding novel type-1 cytokine receptor GLM-R
#262NOVEL TYPE-1 CYTOKINE RECEPTOR GLM-R
#263Effectors of innate immunity
#264Human G-protein chemokine receptor (CCR5) HDGNR10
#265CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection
#266Nucleic acid encoding eosinophil eotaxin receptor
#267Human PF4A receptors, nucleic acid encoding and antibodies binding thereto
#268Human signal peptide-containing proteins
#269Activity of THAP-family chemokine-binding domains
#270Compositions of THAP-family chemokine binding domains
#271Compositions of THAP-family chemokine binding domains
#272Nucleic acids encoding compositions of THAP-family chemokine binding domains
#273DNAXCCR10
#274CCR6 chemokine receptor disruptions, compositions and methods relating thereto
#275Human signal peptide-containing proteins
#276Transgenic mice containing lymphoid-specific GPCR gene disruptions
#277Mouse CXC chemokine receptor
#278Virus-like particles for the induction of autoantibodies
#279Uses of a chemokine receptor for inhibiting HIV-1 infection
#280Transgenic mice containing melanocyte stimulating hormone receptor gene disruptions
#281Human G-protein receptor HGBER32
#282Transgenic mice containing, cGMP phosphodiesterase gene disruptions
#283Methods of treating and diagnosing diabetes with cx3cr1 modulators
#284Mammalian chemokine reagents
#285Transgenic mice containing sulfotransferase gene disruptions
#286Human chemotactic cytokine
#287Human G-protein chemokine receptor (CCR5) HDGNR10
#288Method of predicting genetic risk for hypertension
#289Cyclic peptides and antibodies thereof
#290Enzymatic activities in chemokine-mediated inflammation
#291Macrophage derived chemokine (MDC), MDC analogs, MDC inhibitor substances and uses thereof
#292Human G-protein chemokine receptor HSATU68
#293Therapeutic targeting of PARC/CCL18 and its signaling in pulmonary fibrosis
#294C-C chemokine receptor 3 proteins
#295CXCR6 chemokine receptor gene disruptions, and compositions and methods related thereto
#296Therapeutic chemokine receptor antagonists
#297Method of screening for modulators of HIV infection
#298Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokine
#299Therapeutic uses for MDC and MDC antagonists
#300Chemokine receptor obtained from a cDNA library of fetal liver-spleen